Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

TiO2 Prop 65 Dismissal Offers Lessons, Renews Hope For Industry

This article was originally published in The Tan Sheet

Executive Summary

A win for industry in California Prop 65 litigation targeting titanium dioxide-containing cosmetics illustrates the importance of getting involved early in the listing process and challenging the factual basis for exposure claims. Morrison & Foerster attorney Michael Steel discusses the case and its takeaways.

You may also be interested in...



Sunscreen Ingredient GRASE Guidance Leaves Nanoparticle Gap – NPA

NPA urges FDA to consider adding safety parameters for nanoparticles in its draft guidance for data supporting GRASE determinations in OTC sunscreen time-and-extent applications. In comments, the trade group says safety considerations for nanoparticles are unique.

Sunscreen Makers Could Reel In ‘Superior’ Ingredients From Fish – Study

Combining mycosporines and similar amino acids from the mucous of reef fish and fish eyes with chitosan has “potential to provide an efficient protection against both types of UV radiations and overcome several shortfalls of the current UV-protective products,” recent research concludes.

Sunscreen Makers Could Reel In ‘Superior’ Ingredients From Fish – Study

Combining mycosporines and similar amino acids from the mucous of reef fish and fish eyes with chitosan has “potential to provide an efficient protection against both types of UV radiations and overcome several shortfalls of the current UV-protective products,” recent research concludes.

Related Content

Topics

UsernamePublicRestriction

Register

PS107873

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel